Skip to main content
SpringerLink
Log in
Book cover

Arzneiverordnungs-Report 2000 pp 210–233Cite as

Antirheumatika und Antiphlogistika

  • Chapter

  • 45 Accesses

Zusammenfassung

In der Therapie rheumatischer Erkrankungen einschließlich degenerativer Veränderungen werden vorzugsweise nichtsteroidale Antiphlogistika eingesetzt. Mit ihnen gelingt es, den entzündlichen Prozeß zurückzudrängen, die Beweglichkeit zu verbessern und den entzündlichen Schmerz zu vermindern. Für Glucocorticoide (vgl. ) sind in der Therapie der rheumatoiden Arthritis in den letzten Jahren die Indikationen für eine niedrig dosierte Therapie ausgeweitet worden. Die remissionsinduzierenden antirheumatischen Arzneimittel (langfristig wirkende Antirheumatika, auch als „Basisthera-peutika“ bezeichnet) haben wegen ihrer seltenen Indikation mengenmäßig nur einen geringen Anteil an den Verordnungen der Antirheumatika und Antiphlogistika. Eine kritische Beachtung verdienen die hierzulande besonders viel verwendeten Externa (Rheumasalben und Einreibungen), für die allerdings die abgerechneten Verordnungen 1999 gegenüber dem Vorjahr weiter zurückgegangen sind (Abbildung 16.1).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Arzneimittelkommission der deutschen Ärzteschaft (1997): Empfehlungen zur Therapie von degenerativen Gelenkerkrankungen. Arzneiverordnung in der Praxis. Sonderheft 5, 8.

    Google Scholar 

  • Bauer H.W., Klasser M., von Hanstein K.L., Rolinger H., Schladitz G. et al. (1999): Oxaceprol is as effective as diclofenac in the therapy of osteoarthritis of the knee and hip. Clin. Rheumatol. 18: 4–9.

    Article  PubMed  CAS  Google Scholar 

  • Bundesgesundheitsamt (1987): Monographie der Kommission E über Brennessel-krautextrakt. Bundesanzeiger Nr. 76 vom 23. April 1987.

    Google Scholar 

  • Burnham R., Gregg R., Healy P., Steadward R. (1998): The effectiveness of topical diclofenac for lateral epicondylitis. Clin. J. Sport Med. 8: 78–81.

    Article  PubMed  CAS  Google Scholar 

  • Castell J.V., Friedrich G., Kuhn C.S., Poppe G.E. (1997): Intestinal absorption of undegraded proteins in men: presence of bromelain in plasma after oral intake. Am. J. Physiol. 273: G139–G146.

    PubMed  CAS  Google Scholar 

  • Cryer B., Feldman M. (1998): Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am. J. Med. 104: 413–421.

    Article  PubMed  CAS  Google Scholar 

  • Dequeker J., Hawkey C., Kahan A. et al. (1998): Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the safety and efficacy large-scale evaluation of COX-inhibiting therapies (SELECT) trial in osteoarthritis. Br. J. Rheumatol. 37: 946–951.

    Article  PubMed  CAS  Google Scholar 

  • Dickson DJ. (1991): A double-blind evaluation of topical piroxicam gel with oral ibuprofen in osteoarthritis of the knee. Curr. Ther. Res. 49: 199–207.

    Google Scholar 

  • Diebschlag W. (1986): Diclofenac bei stumpf-traumatischen Sprunggelenkschwellungen. Fortschr. Med. 104: 437–440.

    PubMed  CAS  Google Scholar 

  • Drovanti A., Bignamini A.A., Rovati A.L. (1980): Therapeutic activity of oral glucosamine sulfate in osteoarthrosis: a placebo-controlled double-blind investigation. Clin. Ther. 3: 260–272.

    PubMed  CAS  Google Scholar 

  • Eccles M., Freemantle N., Mason J. (1998): North of England evidence based guideline development project: summary guideline for non steroidal anti-inflammatory drugs versus basic analgesia in treating the pain of degenerative arthritis. Brit. Med. J. 317: 526–530.

    Article  PubMed  CAS  Google Scholar 

  • El Hadidi T., El Garf A. (1991): Double-blind study comparing the use of Voltaren Emulgel versus regular gel during ultrasonic sessions in the treatment of localized traumatic and rheumatic painful conditions. J. Int. Med. Res. 19: 219–227.

    PubMed  CAS  Google Scholar 

  • Emery P., Zeidler H., Kvien T.K., Guslandi M., Naudin R., Stead H. et al. (1999): Celecoxib versus diclofenac in long term management of rheumatoid arthritis: randomized double blind comparison. Lancet 354: 2106–2111.

    Article  PubMed  CAS  Google Scholar 

  • Evans J.M.M., MacDonald T.M. (1996): Tolerability of topical NSAIDs in the elderly. Drugs Aging 9: 101–108.

    Article  PubMed  CAS  Google Scholar 

  • Gondolph-Zink B., Gronwald U. (1996): Wirkstoffkonzentrationen in artikulären und periartikulären Geweben des Kniegelenkes nach kutaner Anwendung von Diclofenac-Diethylammonium Emulgel. Akt. Rheumatol. 21: 298–304.

    Article  Google Scholar 

  • Grace D., Rogers J., Skeith K., Anderson K. (1999): Topical diclofenac versus placebo: a double blind, randomized clinical trial in patients with osteoarthritis of the knee. J. Rheumatol. 26: 2659–2663.

    PubMed  CAS  Google Scholar 

  • Gretzer B., Ehrlich K., Maricic N., Lambrecht N., Respondek M., Peskar B.M. (1998): Selective cyclo-oxygenase 2 inhibitors and their influence on the protective effect of a mild irritant in the rat stomach. Brit. J. Pharmacol. 123: 927–935.

    Article  CAS  Google Scholar 

  • Hawkey C.J. (1999): COX-2 inhibitors. Lancet 353: 307–314.

    Article  PubMed  CAS  Google Scholar 

  • Hawkey C., Kahan A., Steinbrück K., Alegre C., Baumelou E. et al. (1998): Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. Br. J. Rheumatol. 37: 937–945.

    Article  PubMed  CAS  Google Scholar 

  • Hosie G.A.C. (1993): The topical NSAID, felbinac, versus oral ibuprofen: a comparison of efficacy in the treatment of acute lower back injury. Br. J. Clin. Res. 4: 5–17.

    Google Scholar 

  • Hotz G., Frank T., Zoller J., Wiebelt H. (1989): Antiphlogistic effect of bromelaine following third molar removal. Dtsch. Zahnärztl. Z. 44: 830–832.

    PubMed  CAS  Google Scholar 

  • Laine L., Harper S., Simon T., Bath R., Johanson J., Schwartz H. et al. (1999): A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Gastroenterology 117: 776–783.

    Article  PubMed  CAS  Google Scholar 

  • Langman M.J.S., Weil J., Wainwright P., Lawson D.H., Rawlins M.D. et al. (1994): Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 323: 1075-1052.

    Google Scholar 

  • Langman M.J., Jensen D.M., Watson DJ., Harper S.E., Zhao PL., Quan H. et al. (1999): Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDS. JAMA 282: 1929–1933.

    Article  PubMed  CAS  Google Scholar 

  • Masson M. (1995): Bromelain in blunt injuries of the locomotor system. A study of observed applications in general practice. Fortschr. Med. 113: 303–306.

    CAS  Google Scholar 

  • McAlindon T.E., LaValley M.P., Gulin J.P., Felson D.T. (2000): Glucosamine and chondroitin for treatment of osteoarthritis. A systematic quality assessment and meta-analysis. JAMA 283: 1469–1475.

    CAS  Google Scholar 

  • Mitchell J.A., Akarasereenont P., Thiemermann C., Flower R.J., Vane J.R. (1993): Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc. Natl. Acad. Sci. USA 90, 11693–11697.

    Article  PubMed  CAS  Google Scholar 

  • Moore R.A., Tramèr M.R., Caroll D., Wiffen P.J., McQuay H.J. (1998): Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs. Brit. Med. J. 316: 333–338.

    Article  PubMed  CAS  Google Scholar 

  • Müller M., Mascher H., Kikuta C., Schäfer S., Brunner M. et al. (1997): Diclofenac concentrations in defined tissue layers after topical administration. Clin. Pharmacol. Ther. 62: 293–299.

    Article  PubMed  Google Scholar 

  • Newberry R., Shuttleworth P., Rapier C. (1992): A multicentre postmarketing surveillance study to evaluate the safety and efficacy of felbinac 3 % gel in the treatment of musculoskeletal disorders in general practice. Eur. J. Clin. Res. 3: 139–150.

    Google Scholar 

  • Nocker W, Diebschlag W. (1991): Behandlung akuter Sprunggelenkdistorsionen. Z. All. Med. 67: 560–564.

    Google Scholar 

  • Obertreis B., Giller K., Teucher T., Behnke B., Schmitz H. (1996): Antiphlogistische Effekte von Extractum Urticae dioicae foliorum im Vergleich zu Kaffeoyläpfelsäure. Arzneim. Forsch. 46: 52–56.

    CAS  Google Scholar 

  • Pujalte J.M., Llavore E.P., Ylescupidez ER. (1980): Double-blind clinical evaluation of oral glucosamine sulphate in the basic treatment of osteoarthrosis. Curr. Med. Res. Op. 7: 110–114.

    Article  CAS  Google Scholar 

  • Radermacher J., Jentsch D., Scholl M.A., Lustinetz T., Frölich J.C. (1991): Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease. Br. J. Clin. Pharmac. 31: 537–541.

    Article  CAS  Google Scholar 

  • Reichelt A., Förster K.K., Fischer M., Rovati L.C., Setnikar I. (1994): Efficacy and safety of intramuscular glucosamine sulfate in osteoarthritis of the knee. Arzneim. Forsch. 44: 75–80.

    CAS  Google Scholar 

  • Riess W., Schmid K., Botta L., Kobayashi K., Moppert J. et al. (1986): Die perkutane Resorption von Diclofenac. Arzneim. Forsch. 36: 1092–1096.

    CAS  Google Scholar 

  • Rindone J.P., Hiller D., Collacott E., Nordhaugen N., Arriola G. (2000): Randomized, controlled trial of glucosamine for treating osteoarthritis of the knee. West. J. Med. 172: 91–94.

    Article  PubMed  CAS  Google Scholar 

  • Roth S.H. (1995): A controlled clinical investigation of 3% diclofenac/2.5 % sodium hyaluronate topical gel in the treatment of uncontrolled pain in chronic oral NSAID users with osteoarthritis. Int. J. Tissue React. 17: 129–132.

    CAS  Google Scholar 

  • Rovati L.C. (1992): Clinical research in osteoarthritis: design and results of shortterm and long-term trials with disease-modifying drugs. Int. J. Tiss. Reac. 14: 243–251.

    CAS  Google Scholar 

  • Sandholzer H., Kochen M.M. (1991): Perkutane Rheumatherapie. Pharma-Kritik 13: 13–16.

    Google Scholar 

  • Schapira D., Linn S., Scharf Y. (1991): A placebo-controlled evaluation of diclofenac diethylamine salt in the treatment of lateral epicondylitis of the elbow. Curr. Ther. Res. 49: 162–168.

    Google Scholar 

  • Schubotz R., Hausmann L. (1977): Behandlung degenerativer Gelenkerkrankungen mit N-Azetyl-hydroxyprolin. Therapiewoche 27: 4248–4252.

    Google Scholar 

  • Setnikar I., Palumbo R., Canali S., Zanolo G. (1993): Pharmacokinetics of glucosamine in man. Arzneim. Forsch. 43: 1109–1113.

    CAS  Google Scholar 

  • Towheed T.E., Anastassiades T.P. (2000): Glucosamine and chondroitin for treating symptoms of osteoarthritis: evidence is widely touted but incomplete. JAMA 283: 1483–1484.

    Article  PubMed  CAS  Google Scholar 

  • Vagt C.W., Kaiser T., Leineweber G. (1990): Wirksamkeitsvergleich der oralen Therapie mit Oxazeprol versus Ibuprofen bei Gonarthrose und Coxarthrose. Rheuma 10: 263–267.

    Google Scholar 

  • Wallace J.L., Bak A., McKnight W, Asfaha S., Sharkey K.A., Mac Naughton W.K. (1998): Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: Implilcations for gastrointestinal toxicity. Gastroenterology 115: 101–109.

    Article  PubMed  CAS  Google Scholar 

  • Weiss R.F., Fintelmann V. (1997): Lehrbuch der Phytotherapie. 8. Aufl., Hippokrates Verlag Stuttgart, S. 271–281.

    Google Scholar 

  • Zeidler H. (1996): Nichtsteroidale Antiphlogistika. Neue Wege zu einer rationalen, sparsamen und risikoärmeren Verordnung. Akt. Rheumatol. 21: 269–271.

    Article  Google Scholar 

  • Zimmermann J., Siguencia J., Tsvang E. (1995): Upper gastrointestinal hemorrhage associated with cutaneous application of diclofenac gel. Am. J. Gastroenterol. 90: 2032–2034.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Pharmakologie und Toxikologie der Universität, Robert -Koch-Straße 40, 37075, Göttingen, Deutschland

    Gerhard Schmidt

Authors
  1. Gerhard Schmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Pharmakologisches Institut der Universität Heidelberg, Im Neuenheimer Feld 366, 69120, Heidelberg, Germany

    Ulrich Schwabe

  2. Bachstraße 29, 50858, Köln, Germany

    Dieter Paffrath

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Schmidt, G. (2001). Antirheumatika und Antiphlogistika. In: Schwabe, U., Paffrath, D. (eds) Arzneiverordnungs-Report 2000. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56832-9_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56832-9_16

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-67573-0

  • Online ISBN: 978-3-642-56832-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation